Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03160742 · ClinicalTrials.gov registry record
Pilot Study of a Non-Invasive Central Venous Pressure Monitoring System in Children
A clinical trial, sponsored by Boston Children's Hospital.
- Terminated
- Registry status
- 1
- Enrollment target
NCT03160742: Clinical Trial study, sponsored by Boston Children's Hospital.
NCT03160742 is a clinical trial that was terminated before completion, run by Boston Children's Hospital. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03160742 was terminated before completion, sponsored by Boston Children's Hospital.
- TERMINATED
- Registry status
- 1 participants
- Enrollment target
Study Summary
The goal of this research study is to determine the feasibility and accuracy of Mespere Life Science non-invasive central venous pressure monitoring system (Mespere VENUS 2000CVP system) in children with congenital heart disease (CHD).
Primary Outcome
The correlation between the non-invasive measurements from the Mespere VENUS 2000CVP system and the invasive central venous pressure measurements that are continuously collected as standard of care.
Interventions
- DEVICE Mespere VENUS 200CVP system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2018-04-25 |
| Est. Completion | 2018-09-14 |
Why NCT03160742 stopped before completion
NCT03160742 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 1 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Mespere VENUS 200CVP system is the first listed.
NCT03160742 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03160742 about?
NCT03160742 is a clinical study titled "Pilot Study of a Non-Invasive Central Venous Pressure Monitoring System in Children". The goal of this research study is to determine the feasibility and accuracy of Mespere Life Science non-invasive central venous pressure monitoring system (Mespere VENUS 2000CVP system) in children with congenital heart disease (CHD).
What is the current status of trial NCT03160742?
This trial is currently terminated. The enrollment target is 1 participants. The study started on 2018-04-25. Estimated completion is 2018-09-14.
What interventions are being tested in trial NCT03160742?
The interventions under investigation include: Mespere VENUS 200CVP system (DEVICE).
Who is sponsoring clinical trial NCT03160742?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI